Aliskiren Tablet, Film Coated
Product Images NDC 49884-424

5 FDA label images from Par Health Usa, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Aliskiren (NDC 49884-424). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Par Health Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Aliskiren-chem-stru (Aliskiren 1)

Aliskiren-chem-stru (Aliskiren 1)
Chemical structure of aliskiren, showing its molecular framework with functional groups including amine, hydroxyl, and carboxyl components.*
FDA Label Image

Aliskiren (Aliskiren 2)

Aliskiren (Aliskiren 2)
A chart showing the impact of co-administered drugs on the pharmacokinetics of aliskiren. It depicts fold changes with 90% confidence intervals in Cmax and AUC for various interacting drugs classified as CYP3A4/P-gp inhibitors, antihypertensives, and others. Recommendations for dose adjustment or caution are listed alongside.*
FDA Label Image

Aliskiren (Aliskiren 3)

Aliskiren (Aliskiren 3)
A pharmacokinetic impact chart showing the fold change and 90% confidence intervals of co-administered drugs with aliskiren. The chart compares Cmax and AUC values for various antihypertensives and other drugs, with a vertical reference line at 1.00 indicating no change. Recommendations for all drugs indicate no dose adjustment is needed.*
FDA Label Image

Label-150_mg-30s_-_par.jpg (Aliskiren 4)

Label-150_mg-30s_-_par.jpg (Aliskiren 4)
Label for Aliskiren Tablets 150 mg film-coated oral tablets by Par Health USA, LLC. The package contains 30 tablets. Active ingredient listed as Aliskiren Hemifumarate 165.765 mg equivalent to Aliskiren 150 mg. Storage instructions note to keep at 20° to 25°C, tightly closed, and protect from moisture.*
FDA Label Image

Label-300_mg-30s_-_par.jpg (Aliskiren 5)

Label-300_mg-30s_-_par.jpg (Aliskiren 5)
Label for Aliskiren Tablets 300 mg oral film-coated tablets. The package contains 30 tablets and is manufactured by Par Health USA, LLC. The label includes storage instructions, dosage note to see package insert, and a barcode on the right side. The active ingredient amount is specified as Aliskiren Hemifumarate 331.530 mg equivalent to Aliskiren 300 mg per tablet.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.